National Cancer Institute
National Cancer Institute
Bratislava, Slovakia1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, neoplasm | Recruiting | Phase 2 | 2026-09-25 | NCT07121322 |